Certified Advisory Corp’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.12M | Sell |
16,212
-246
| -1% | -$57.3K | 0.33% | 81 |
|
|
2026
Q1 | $4.02M | Sell |
16,458
-584
| -3% | -$136K | 0.36% | 76 |
|
|
2025
Q4 | $3.53M | Sell |
17,042
-639
| -4% | -$126K | 0.32% | 81 |
|
|
2025
Q3 | $3.28M | Sell |
17,681
-1
| -0% | -$171 | 0.31% | 83 |
|
|
2025
Q2 | $2.7M | Sell |
17,682
-1,377
| -7% | -$212K | 0.28% | 92 |
|
|
2025
Q1 | $3.16M | Buy |
19,059
+265
| +1% | +$41.5K | 0.36% | 79 |
|
|
2024
Q4 | $2.72M | Sell |
18,794
-486
| -3% | -$75.3K | 0.3% | 90 |
|
|
2024
Q3 | $3.12M | Sell |
19,280
-125
| -0.6% | -$19.9K | 0.35% | 83 |
|
|
2024
Q2 | $2.84M | Sell |
19,405
-347
| -2% | -$51.6K | 0.36% | 84 |
|
|
2024
Q1 | $3.12M | Buy |
19,752
+511
| +3% | +$81.3K | 0.44% | 68 |
|
|
2023
Q4 | $3.02M | Buy |
19,241
+613
| +3% | +$94K | 0.46% | 71 |
|
|
2023
Q3 | $2.9M | Sell |
18,628
-588
| -3% | -$97K | 0.53% | 62 |
|
|
2023
Q2 | $3.18M | Sell |
19,216
-1,327
| -6% | -$214K | 0.58% | 52 |
|
|
2023
Q1 | $3.18M | Sell |
20,543
-251
| -1% | -$40.5K | 0.57% | 50 |
|
|
2022
Q4 | $3.67M | Buy |
20,794
+249
| +1% | +$43K | 0.73% | 36 |
|
|
2022
Q3 | $3.36M | Sell |
20,545
-1,006
| -5% | -$170K | 0.77% | 33 |
|
|
2022
Q2 | $3.83M | Buy |
21,551
+1,082
| +5% | +$193K | 0.85% | 30 |
|
|
2022
Q1 | $3.63M | Sell |
20,469
-659
| -3% | -$112K | 0.77% | 34 |
|
|
2021
Q4 | $3.61M | Sell |
21,128
-123
| -0.6% | -$20.1K | 0.8% | 34 |
|
|
2021
Q3 | $3.43M | Sell |
21,251
-220
| -1% | -$37.5K | 0.83% | 33 |
|
|
2021
Q2 | $3.54M | Sell |
21,471
-282
| -1% | -$46.7K | 0.89% | 27 |
|
|
2021
Q1 | $3.58M | Buy |
+21,753
| New | +$3.52M | 0.93% | 23 |
|
|
2020
Q2 | $2.9M | Buy |
20,596
+1,756
| +9% | +$256K | 0.96% | 22 |
|
|
2020
Q1 | $2.47M | Sell |
18,840
-390
| -2% | -$55.3K | 0.98% | 24 |
|
|
2019
Q4 | $2.81M | Sell |
19,230
-1,678
| -8% | -$228K | 0.9% | 22 |
|
|
2019
Q3 | $2.71M | Sell |
20,908
-599
| -3% | -$78.9K | 0.94% | 20 |
|
|
2019
Q2 | $3M | Sell |
21,507
-197
| -0.9% | -$27.3K | 1.11% | 17 |
|
|
2019
Q1 | $3.03M | Sell |
21,704
-79
| -0.4% | -$10.6K | 1.27% | 16 |
|
|
2018
Q4 | $2.81M | Sell |
21,783
-253
| -1% | -$35.3K | 1.46% | 15 |
|
|
2018
Q3 | $3.04M | Sell |
22,036
-1,060
| -5% | -$141K | 1.41% | 16 |
|
|
2018
Q2 | $2.8M | Sell |
23,096
-340
| -1% | -$42.4K | 1.56% | 13 |
|
|
2018
Q1 | $3M | Buy |
23,436
+3,737
| +19% | +$505K | 1.78% | 10 |
|
|
2017
Q4 | $2.75M | Buy |
+19,699
| New | +$2.74M | 1.98% | 11 |
|
Other funds holding JNJ
PAM
WT
CGI
Certified Advisory Corp's JNJ Position: Q2 2026 in Review
Certified Advisory Corp reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2026, selling an estimated $57.3K and leaving 16,212 shares worth $4.12M. The position accounts for 0.33% of the portfolio, ranked #81.
Certified Advisory Corp first reported a position in JNJ in Q4 2017 and has held it in 33 quarters since. 1,808 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Certified Advisory Corp held 16,212 shares of Johnson & Johnson worth $4.12M as of Q2 2026.
- Certified Advisory Corp sold 246 Johnson & Johnson shares in Q2 2026, an estimated $57.3K.
- Johnson & Johnson made up 0.33% of Certified Advisory Corp's portfolio in Q2 2026, its #81 holding.
- Certified Advisory Corp first reported a position in Johnson & Johnson in Q4 2017 and has held it in 33 quarters since.
- 1,808 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Certified Advisory Corp's 13F filing for Q2 2026, filed 16 Jul 2026.